Three-dimensional cell culturing to capture a life-like experimental environment has become a versatile tool for basic and clinical research. Mucosal and skin tissues can be grown as "organoids" in a petri dish and serve a wide variety of research questions. Here, we report our experience with human cervical organoids which could also include an immune component, e.g.
| BACKGROUND
Three-dimensional culture of human keratinocytes has been an ongoing progress for more than four decades starting as in vitro skin grafting for clinical purposes [1] . Next-generation "organoids" not only contained skin components (keratinocytes, fibroblasts and dermal collagen) but also immune cells to study the role of innate and adaptive immunity, e.g. lymphocytes [2] and epithelium-specific dendritic cells (DCs)-Langerhans cells (LCs) [3] . Regarding LCs, a technical advance with better reproducibility may be the bone marrow-derived cell line called MUTZ-3 [4] which can be matured into DCs and LCs using specific cytokine cocktails [1, 5] .
Currently, the Gibbs group seems to be making use of this approach most extensively, e.g. in the context of allergy [5] . LCs typically make up approximately 1-3% of epithelial tissues [6] , a ratio that is very precise [7] .
Nevertheless, the Gibbs lab used equally many or even twice the amount for organoids compared to the number of keratinocytes. Not all cytokine-treated MUTZ-3 cells differentiate into CD1a + / CD207 + LCs. Indeed, a proportion of differentiated LCs could "switch back", die or not attach, especially in an organoid scenario due to LCs maturing and migrating out of the epithelium before it is harvested. Obtained LC ratio in fully-grown organoids was not systematically investigated in any previous study. A comprehensive protocol is likewise lacking in the scientific literature. Here, we describe a process where the sub-group of LCs is further "enriched" allowing to seed a realistic proportion of myeloid cells (2 vs 20% relative to keratinocytes) resulting in multi-layered, differentiated cervical epithelium. This model, with or without LCs, can be used for investigations in health and disease where stratified epithelia are required for valid inferences. 4
| QUESTIONS ADDRESSED
A framework for incorporating LCs into a keratinocyte organoid model is discussed in our recent publication [1] , which revealed that incorporating these cells into the model is challenging. We wanted to avoid using an excess of LCs as this may hinder multi-layered epithelial differentiation and asked the following questions: A. Does further enrichment of the CD207 + LCs allow us to use fewer myeloid cells than previously described? B. How many myeloid cells are required to obtain a clinically relevant number of LCs in the harvested organoid? C. What are the conditions to obtain properly differentiated organoids reminiscent of human cervical epithelium when interfacing with LCs?
| EXPERIMENTAL DESIGN
While our focus is on human cervical epithelium, we describe an "aseptic" organoid tested for mucosa, as well as skin, with broad applicability: e.g. commensal microorganisms of healthy tissue; pathogens including bacteria, fungi, protozoan parasites and RNA and DNA viruses, alone or in combination, as well as any other disease affecting mucosal and skin epithelia. Our research questions pertain to human papillomavirus (HPV) evolution and persistence leading to cancer, specifically regarding sub-lineages of type 16 [1, 8, 9] .
We have optimized cytokine-induced differentiation of MUTZ-3 cells into LCs (CD1a + /CD207 + , assessed via flow cytometry) and have attempted incorporating them into the organoid model. Experiments were performed using magnetic-enrichment to purify the differentiated MUTZ-3 (10-30% population of CD1a + /CD207 + when "unpurified") and seeding different ratios of these cells relative to the primary human keratinocytes (2%, a realistic mean amount found in epithelia, assuming all embed vs 20%, 10x greater, in case there was loss). The same approach was performed using LCs without further purification. Altogether five 5 experimental raft groups were grown. Group 1 contained cervical keratinocytes only; groups 2 and 3 contained purified (~ 98%) LCs at a ratio of 1:50 (10 000 LCs/500 000 keratinocytes) and 1:5 (100 000 LCs/500 000 keratinocytes), respectively; groups 4 and 5 contained unpurified (~ 20%) LCs at a ratio of 1:10 (50 000 LCs/500 000 keratinocytes) and 1:1 (500 000 LCs/500 000 keratinocytes), respectively. Experiments, cells and reagents are fully described in Supporting Information. All required cells and reagents can be obtained commercially.
| RESULTS & DISCUSSION
The complex experimental design to grow organoids requires skilled lab hands, the ability to multi-task and coordinate lab work, organizing the substantial reagent stocks needed and the capacity to troubleshoot and find solutions. Knowledge of tissue morphology is essential as the detection of tissue-embedded LCs may be challenging for the inexperienced investigator.
The time of LC seeding is crucial. We reckoned that it would be best to seed the LCs two hours after seeding the cervical keratinocytes as we know from previous experiments over the years of rafting that keratinocytes need approximately that time to adhere to the underlying dermal equivalents. Two independent proficient observers (R.J., I.Z.) calculated total keratinocyte yield using DAPI-stained nuclei as their criterion using the Northern Eclipse or ImageJ software counting feature. LC identification was pre-screened by R.J. and randomly confirmed by I.Z.
Optimal epithelial stratification was associated with increased purity and a lower ratio of LCs, as expected. Notably, tissue culture medium collections just before lifting the rafts to the air-liquid interface showed shed cells relative to the number of LCs seeded, but most for group 5 followed by groups 3, 4 and 2. Using 10-fold of the expected LC presence (group 3) yielded ~ 1% in the harvested rafts (i.e. within the normal range) rather than 20%. It could be possible that a large number of the LCs did not survive through the 2-week rafting period (perhaps due to lack 6 of optimal medium containing essential cytokines such as IL-4 and TNF-a). Using serial sections along with optimization of the immunostaining finally yielded their (rare) detection (Figure 1 ). Using formaldehyde-fixed and paraffin-embedded tissue, antigen retrieval had to be performed with Tris-HCl (pH 9) rather than citrate buffer (pH 6). Only then, could langerin+ (CD207) LCs be detected at a physiologically relevant level (~ 1%) in rafts of group 3. Groups 2, 4 and 5 resulted in a detection rate of > 1%. It should be noted that the langerin+ micrographs presented in this figure are not a complete reflection of the ratio that has identified in the organoids.
Prior to embarking on the complex organoid containing LCs, it may be worth considering that innate immunity can be assessed without LCs, using endogenous keratinocyte pathways and 
| CONCLUSIONS
We sought to develop a reproducible immune-competent cervical organoid model with retained tissue integrity (e.g. differentiation). While we deem our described technical approach successful, due to the scarce presence of LCs in vivo (and in our model), it is debatable whether we will detect differences in the expression of the numerous immunomarkers expected in the HPV-infected cervical epithelium. To detect even subtle changes of such markers, a careful power analysis defining the appropriate sample size will be essential for our and others' investigations. Nevertheless, the fact that LCs are known to be relatively scarce in the cervical mucosa and that most HPV infections are cleared, it would be intriguing to be able to distinguish immune marker expression between their presence and absence in the engineered cervical organoid. Alternatively, LCs may not have the importance that we hypothesize, and may be minor actors in the HPV-infected epithelial microenvironment. #C353136] as reported previously [2] ; human dermal fibroblasts are grown in DMEM+ 10% FBS + 1% AB/AM and expanded as described below or needed.
Organoid rafting procedure
This multi-step process requiring sterilized tools, preparation of several reagents and a good pair of steady lab hands, takes three days to prepare the organoids after which they have to grow for 14 days to mature to full-thickness epithelium. of an anticipated 500 000 keratinocytes upon an additional doubling after their initial seeding) kept in 50 µL of PBS [Fisher Scientific, Cat. #SH30028.02] and incubate for 30 min to improve attachment [3] ; top up with 400 µL complete EpiLife medium to allow one more population doubling before differentiation medium is applied the next day (amounting to 500 000 cells before rafts are lifted). This calculation only applies to the further purified LC populations using magnetic beads with close to 100% double positive CD1a + /CD207 + LCs (i.e. experimental groups #2 and 3). Based on previous work by our Dutch colleagues [4] , further purification like ours is not described which leaves us with only ~ 20% CD207 + LCs. Hence for experimental groups #4 and 5, we used 50 000 and 500 000 cells respectively, of which the latter approximately equals their 1:1 epithelial-myeloid cell ratio.
Day 3: lifting to the air interphase is the most intricate part of the process requiring a steady hand and a small lifting spoon [e.g. Fisher Scientific, Cat. #21-401-15] to position the rafts, following careful aspiration of the medium on top, to round membrane inserts [Millipore Sigma, Cat.
#PICMORG50] in 6-well plates; differentiation medium CnT-Prime 3D Barrier [CELLNTEC,
Cat. #CNT-PR-3D] is now applied at 1.1 mL/well.
During the 14-day growth, medium changes occur every 2 days, collected medium is frozen to -80°C (optional) to assess the supernatants for cytokines and growth factors if desired:
24 h prior to harvest, BrdU (10 µM final concentration) can be added to monitor proliferation (optional); also e.g. drug treatment or other manipulation can be administered as determined by study design.
Organoid harvest

